Inactive Instrument
Quest PharmaTech Inc. Stock Other OTC
Stocks
QPTFF
CA74836M1068
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 4.23M 2.98M 2.6M 2.39M 2.23M 283M 4.29M 28.71M 11.16M 139M 11.17M 10.93M 480M | P/E 2025 |
-3.29x | P/E 2026 | 1.18x |
|---|---|---|---|---|---|
| Enterprise Value | 5.21M 3.67M 3.21M 2.95M 2.75M 350M 5.29M 35.4M 13.76M 172M 13.78M 13.48M 592M | EV / Sales 2025 |
-
| EV / Sales 2026 | - |
| Free-Float |
83.12% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | -34.61% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 17/06/2004 | |
Pierre Vermette
DFI | Director of Finance/CFO | - | 01/01/2005 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 17/06/2004 | |
J. Lievonen
CHM | Chairman | - | 05/07/2021 |
Jeffrey Shon
BRD | Director/Board Member | - | 05/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -34.61% | +0.12% | - | - | 2.98M | |
| +1.70% | +7.41% | +3.12% | +8.46% | 49.15B | |
| +0.92% | +6.21% | +408.85% | +607.44% | 40.23B | |
| +1.89% | +11.06% | +25.75% | -7.89% | 34.55B | |
| +5.46% | +8.10% | +21.83% | +66.94% | 33.09B | |
| +3.96% | +6.07% | +14.14% | +37.68% | 25.19B | |
| +2.51% | +4.94% | - | - | 17.05B | |
| +2.58% | +7.24% | +71.03% | +132.17% | 15.92B | |
| +0.32% | +1.58% | +14.34% | +19.26% | 13.83B | |
| -1.14% | +7.52% | +14.75% | -30.83% | 13.26B | |
| Average | -1.98% | +4.79% | +71.72% | +104.15% | 26.92B | |
| Weighted average by Cap. | +1.74% | +5.31% | +89.22% | +131.91% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.8M -1.27M -1.11M -1.02M -950K -121M -1.83M -12.23M -4.75M -59.35M -4.76M -4.66M -205M | 5M 3.52M 3.08M 2.83M 2.64M 335M 5.07M 33.94M 13.19M 165M 13.21M 12.93M 568M |
| Net Debt | 795K 560K 489K 450K 419K 53.29M 807K 5.4M 2.1M 26.19M 2.1M 2.06M 90.26M | 986K 694K 607K 558K 520K 66.07M 1M 6.69M 2.6M 32.48M 2.6M 2.55M 112M |
Employees
-
